Z01 CP010177 (Z01) | |||
---|---|---|---|
Title | HPV Vaccine Trials | ||
Institution | NCI, Bethesda, MD | ||
Principal Investigator | Hildesheim | NCI Program Director | N/A |
Cancer Activity | N/A | Division | DCEG |
Funded Amount | $2,552,153 | Project Dates | 12/01/2000 - N/A |
Fiscal Year | 2007 | Project Type | Intramural |
Research Topics w/ Percent Relevance | Cancer Types w/ Percent Relevance | ||
N/A | Cervical Cancer (87.784%) | ||
Research Type | |||
Endogenous Factors in the Origin and Cause of Cancer Vaccines |
|||
Abstract | |||
Infections with oncogenic types of HPV cause virtually all cases of cervical cancer worldwide. Prophylactic vaccination against HPV 16 and 18, two of the most important HPV types, could protect against a large majority of the cases of cervical cancer glo |